Michael D. Lucroy, DVM, MS, DACVIM (oncology)

Michael D. Lucroy, DVM, MS, DACVIM (oncology), is chief medical officer at Torigen Pharmaceuticals, a startup biotechnology company focused on cancer immunotherapy for the veterinary market. Before joining Torigen, he was director of clinical studies for MedVet emergency and specialty hospitals. He also spent nearly 2 decades in academic and private specialty practice.